The clinical performance is complex and often involves multi-system congestion. Early identification and standardized diagnosis are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnostics and treatment programs. Treatment and management of the treatment program alongside the PML brain room require individualized development, typically including multidimensional management of drugs, rehabilitation interventions, and regular follow-up visits. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many formerly difficult-to-treat neurological disorders have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, adjusted in a timely manner according to the changes in the disease. Multidisciplinary collaborations (MDT) are particularly important for the integrated management of the PML companion brain chambers. The platform serves a team of domestic and foreign experts in the field of neural systems related to the China International Medical Service System, providing the following services to patients: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.